GSK

Laval, Canada Founded: 1993 • Age: 33 yrs Listed Acquired By GSK
GSK is engaged in developing biopharmaceutical solutions globally.

About GSK

GSK is a Healthcare company based in Laval (Canada) founded in 1993, and was acquired by GSK in April 2023. GSK is engaged in developing biopharmaceutical solutions globally. It operates on a Direct-to-Consumer (D2C) and Professional Services model. GSK offers products and services including Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions. Its focus areas include Pharmaceuticals and Biopharmaceuticals. Its legal entity is GSK plc.

Company details

GSK, a focused biopharmaceutical company, is dedicated to uniting science, technology, and talent to address diseases. Operations are centered on four therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. Solutions are developed to improve global health, with a commitment to impact 2.5 billion people by the end of the decade. Efforts are made to ensure access through responsible pricing and partnerships, while sustainability and ethical standards are prioritized across all activities.

  • Headquarters Laval, Canada
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bellushealth.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Acquired by GSK (Apr 2023)
  • Legal Name Gsk Plc
Key Metrics

Products & Services of GSK

GSK offers a comprehensive portfolio of products and services, including Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions.

Respiratory Treatments
Pharmaceuticals

Solutions for respiratory conditions are developed and provided.

Oncology Therapies
Pharmaceuticals

Cancer treatments are researched and offered for patients.

HIV Medications
Pharmaceuticals

HIV therapies are created to manage the condition.

Infectious Disease Solutions
Pharmaceuticals

Treatments for infectious diseases are developed and distributed.

Apps and channels of GSK

its YouTube channel ViiV Healthcare has 133 subscribers and 30 videos.

ViiV Healthcare
YouTube 133 subscribers 30 videos Autos & Vehicles
Open channel

Videos from GSK

The most watched videos on GSK's YouTube channel, ViiV Healthcare (133 subscribers). Click a video to play it here.

Bridging the gap between clinical trials and real life in HIV care
532.5K views
The potential of bNAbs
11.4K views
Take My Hand
2.2K views
We can end the HIV epidemic, FULL STOP.
1.9K views

More on ViiV Healthcare.

Funding Insights of GSK

  • Total Rounds 4
  • Last Round Post-IPO β€” $35M
  • First Round $9.61M

    (Dec 2017)

  • Investors Count 8

All 4 funding rounds of GSK with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2019$35MPost-IPO––
Dec 2018$25.68MPost-IPO––
–
Jan 2018$400,000Post-IPO––
Dec 2017$9.61MPost-IPO––
–
Valuation history

9 investors in total: 9 institutional.

Investors in GSK

GSK has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include New Leaf Venture Partners, Orbimed and GSK.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
1989orbimed.comNew York, United States
Stage-agnostic investments in US life sciences are managed.
2005nlvpartners.comNew York, United States
amzak.com
Venture capital funding is provided by Samsara BioCapital in California.
samsaracap.comPalo Alto, United States
Apple Tree Partners is engaged in life sciences venture capital.
appletreepartners.com
Provides investment advisory, wealth planning, and portfolio management for clients.
1964firstmanhattan.comNew York, United States
Offers savings plans, investments, and financing for businesses and individuals.
1983fondsftq.comMontreal, Canada
Taro Pharmaceutical Industries is engaged in developing and distributing pharmaceuticals.
1950taro.comHaifa, Israel
Developer of pharmaceuticals and vaccines for various therapeutic areas
1715gsk.comBrentford, United Kingdom
Premium access

Investor details for GSK

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of GSK

15 people are tracked at GSK (1 in leadership, 13 in board & advisors, 1 in team).

NameRoleGroup
Andreas Orfanos
COOLeadership
Francesco Bellini
ChairmanBoard & advisors
Youssef L. Bennani
Board MemberBoard & advisors
Franklin M. Berger
Board MemberBoard & advisors
Clarissa Desjardins
Board MemberBoard & advisors
Pierre Larochelle
Board MemberBoard & advisors
William Mezzanotte
Board MemberBoard & advisors
Joseph Rus
Board MemberBoard & advisors
Jacky Smith
Board MemberBoard & advisors
Alan Goldsobel
Board MemberBoard & advisors
James Hull
Board MemberBoard & advisors
Lorcan McGarvey
Board MemberBoard & advisors
Alyn Morice
Board MemberBoard & advisors
Mandel Sher
Board MemberBoard & advisors
Roussen Pascal
Senior Project ManagerTeam
Premium access

Complete people profiles for GSK

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of GSK

5 dated milestones of GSK across 30 years, from founding to its latest funding, stage changes and deals.

  1. Founded GSK is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $9.6M.
  4. Funding Latest funding round, Post-IPO, of $35.0M.
  5. Exit Acquired by GSK.

Web traffic of GSK

Websites that share an audience with GSK (bellushealth.com).

Similar websites

Websites whose visitors overlap most with GSK. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
itrlab.com
100%
3.4K#6,482,934View details
hea.sagepub.com
hea.sagepub.com
54%
–
oculist.net
oculist.net
54%
#2,386,577–
makronova.com
makronova.com
54%
–
mhealth.org
mhealth.org
54%
–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Gsk

Premium access

Complete news archive for GSK

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about GSK

GSK was founded in 1993 and raised its 1st funding round 24 years after it was founded.

GSK is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.

GSK, a focused biopharmaceutical company, is dedicated to uniting science, technology, and talent to address diseases. Operations are centered on four therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. Solutions are developed to improve global health, with a commitment to impact 2.5 billion people by the end of the decade. Efforts are made to ensure access through responsible pricing and partnerships, while sustainability and ethical standards are prioritized across all activities.

GSK offers Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions.

GSK has 9 investors. Key investors include New Leaf Venture Partners, Orbimed, GSK, Taro Pharmaceutical Industries, and First Manhattan.

GSK operates through Gsk Plc.

Yes. GSK was acquired by GSK in April 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available